Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04384848 · ClinicalTrials.gov registry record · NA
The EMPATHY Pilot Study
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT04384848 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 94 participants.
The verdict
NCT04384848, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
The proposed study, may significantly contribute to improve healthcare delivery in patients with Chronic Myeloid Leukemia (CML) treated with modern tyrosine kinase inhibitors (TKIs) in two ways. First, it may provide novel empirical data on the positive effects of systematically monitoring of patient-reported adverse events (AEs) in routine practice for improving symptom management and adherence to therapy. Second, it will inform the development of a large international randomized controlled trial (RCT) to test whether systematic collection of patient-reported AEs, could improve clinical response to TKI therapy.
Interventions
- OTHER EMPATHY Pilot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2022-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04384848
The ClinicalTrials.gov registry entry for NCT04384848 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EMPATHY Pilot is the first listed.
NCT04384848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04384848 about?
NCT04384848 is a clinical study titled "The EMPATHY Pilot Study". The proposed study, may significantly contribute to improve healthcare delivery in patients with Chronic Myeloid Leukemia (CML) treated with modern tyrosine kinase inhibitors (TKIs) in two ways. First, it may provide novel empirical data on the positive effects of systematically monitoring of patien...
What is the current status of trial NCT04384848?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2019-11-01. Estimated completion is 2022-07-31.
What interventions are being tested in trial NCT04384848?
The interventions under investigation include: EMPATHY Pilot (OTHER).
Who is sponsoring clinical trial NCT04384848?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.